DEPSCREEN-INFO: Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback

Sponsor

Universitätsklinikum Hamburg-Eppendorf (Other)

Overall Status

Completed

CT.gov ID

NCT01879111

Collaborator

German Federal Ministry of Education and Research (Other)

4,151

Enrollment

Locations

Arms

Duration (Months)

2075.5

Patients Per Site

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Out-patients with coronary heart disease or hypertension will fill out a depression screening questionnaire while waiting in a cardiac clinic. Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment. Patients in the control group receive no direct screening-feedback but their cardiologist will be informed about the screening result. All patients with a positive screening-result will be contacted after one month and six months and asked for symptoms of depression, and their use of health care. The aim of this study is to evaluate the efficiency of this minimal intervention on the course of depressive symptom in patients with known coronary heart disease or hypertension.

Condition or Disease	Intervention/Treatment	Phase
Depressive Episode Chronic Ischaemic Heart Disease Hypertension	Other: patient-targeted feedback	N/A

Detailed Description

The aim of this study is to evaluate the efficiency of a minimal intervention on the course of depressive symptoms in patients with known coronary heart disease (CHD) or hypertension. By means of a depression screening and individual patient-targeted feedback the level of depression should decrease, the percentage of treated depressed patients should increase and health economic costs should be lowered. The main hypothesis is that screening plus targeted feedback results in a greater reduction of depression than screening only.

Study Design

Study Type:

Interventional

Actual Enrollment :

4151 participants

Allocation:

Randomized

Intervention Model:

Factorial Assignment

Masking:

Single (Outcomes Assessor)

Primary Purpose:

Screening

Official Title:

Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback: Randomized Controlled Trial

Study Start Date :

Oct 1, 2011

Actual Primary Completion Date :

Oct 1, 2013

Actual Study Completion Date :

May 1, 2014

Arms and Interventions

Arm	Intervention/Treatment
Experimental: state-of-art depression screening + patient-targeted feedback Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment.	Other: patient-targeted feedback Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment.
No Intervention: state-of-art depression screening

Arm

Intervention/Treatment

Experimental: state-of-art depression screening + patient-targeted feedback

Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment.

Other: patient-targeted feedback

No Intervention: state-of-art depression screening

Outcome Measures

Primary Outcome Measures

Level of depression one month after screening (Patient Health Questionnaire-9) [One month after depression screening]

Secondary Outcome Measures

Level of depression six months after screening (Patient Health Questionnaire-9) [One month and six months after screening]
Proportion of patients treated for depression. [One month and six months after screening]
Direct and indirect health costs [One month and six months after screening]
Quality-adjusted years of life and quality of life (EuroQol-5D) [One month and six months after screening]